[1] |
Guo Zehao, Zhang Junwang.
Role of PFDN and its subunits in tumorigenesis and tumor development
[J]. Journal of International Oncology, 2024, 51(6): 350-353.
|
[2] |
Xu Fenglin, Wu Gang.
Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2024, 51(6): 359-363.
|
[3] |
Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.
Research progress of myeloid-derived suppressor cells in tumor angiogenesis
[J]. Journal of International Oncology, 2024, 51(1): 50-54.
|
[4] |
Ye Tongtong, Wu Zeyu, Xi Wenyi, Wang Zhiwei, Jiang Xiaochun, Zhao Chenhui.
Role of ABRACL in the occurrence and development of malignant tumors
[J]. Journal of International Oncology, 2023, 50(9): 544-547.
|
[5] |
Pan Shulan, Liu Chang, He Ping.
Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer
[J]. Journal of International Oncology, 2023, 50(8): 457-462.
|
[6] |
Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.
Current status of research on exosomes in malignancies
[J]. Journal of International Oncology, 2023, 50(8): 484-488.
|
[7] |
Gu Anqin, Long Jinhua, Jin Feng.
Clinical research progress of immunotherapy for nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2023, 50(5): 299-303.
|
[8] |
Liu Yujie, Zhao Zhiqiang, Wang Zicheng.
Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer
[J]. Journal of International Oncology, 2023, 50(12): 717-722.
|
[9] |
Deng Lili, Duan Xingyu, Li Baozhong.
Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma
[J]. Journal of International Oncology, 2023, 50(12): 751-757.
|
[10] |
Li Lixi, Wen Tingyu, Guan Xiuwen, Zhai Jingtong, Ma Fei.
Genetic susceptibility genes and clinical features of early-onset breast cancer
[J]. Journal of International Oncology, 2022, 49(4): 206-209.
|
[11] |
Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen.
Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system
[J]. Journal of International Oncology, 2021, 48(9): 515-522.
|
[12] |
Yu Jiaojiao, Wang Jun, Wang Likang, Yao Nan.
Advances in the amplification of HER2 in metastatic colorectal cancer
[J]. Journal of International Oncology, 2021, 48(4): 246-249.
|
[13] |
Peng Ya, Liu An, Liu Huowang.
Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice
[J]. Journal of International Oncology, 2021, 48(3): 136-142.
|
[14] |
Zhu Lei, Huang Jianbo.
Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2021, 48(2): 74-79.
|
[15] |
Luo Wenxiao, Wu Dehua, Cai Longmei.
Prognostic values of immune efficacy biomarkers in the treatment of nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2021, 48(12): 743-746.
|